University Communications and Marketing records

62, 50937 Cologne, Germany. 1University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany. This retrospective, multicenter study aimed to reveal risk predictors for mortality in the intensive care unit (ICU) as well as survival after ICU discharge in patients with acute myeloid leukemia (AML) requiring treatment in the ICU.

We prospectively assessed disease severity using Hurley staging and the modified Hidradenitis Suppurativa Score in 355 patients referred to Ruhr-University Bochum Department of Dermatology between March 2016 and June 2017. We also assessed disease severity via the Severity Assessment of Hidradenitis Suppurativa score. To identify factors associated with short-term, intermediate and long-term outcome in patients with infective endocarditis (IE) and the need for treatment on intensive care unit (ICU).

A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease

Department I of Internal Medicine, University Hospital Cologne, Kerpener Strasse 62, D-50924 Köln, Germany. Department I of Internal Medicine, University Hospital of Cologne, 50937 Cologne, Germany. 1st Department of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Cologne Interventional Immunology, University Hospital of Cologne, Cologne, Germany; Stem Cell Transplantation Program, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Department of Nephrology and General Internal Medicine, University Hospital of Cologne, Cologne, Germany.

Department I of Internal Medicine, University of Köln, Kerpenerstrasse 62, 50937 Cologne, Germany. Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany. 1Department III of Internal Medicine, Heart Center, University Hospital of Cologne, Kerpener Str.

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Critical Care Medicine, University of Cologne, Cologne, Germany. Molecular Tumor Biology and Tumor Immunology Clinic I for Internal Medicine, University of Cologne, Joseph-Stelzmann Str 9/Haus 16, 50931 Cologne, Germany. Molecular Tumor Biology and Tumor Immunology, Clinic I for Internal Medicine, University of Cologne, Joseph-Stelzmann Strasse 9/Haus 16, 50931 Cologne, Germany. 1st Department of Internal Medicine, University of Cologne, 50924 Cologne, Germany.

Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Founding Member, Intensive Care in Hemato-Oncologic Patients (iCHOP), Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany. Department I of Internal Medicine, Intensive Care Unit, University Hospital of Cologne, Cologne, Germany.

denny gerd silling

Leave a Comment

Your email address will not be published. Required fields are marked *

*
*